Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors by Shingo Tsuji, Katherine A Reil, Elsa Molina, Kinsey L Nelson, Kathleen L McGuire, Matthew J Giacalone

Get full text

1116 VAX014 as a novel oncolytic agent for STING and RIG-I-positive solid tumors by Matthew Giacalone, Shingo Tsuji, Katherine A Reil, Kathleen L McGuire, Kinsey Nelson, Amanda Parikh, Carrie D House

VAX014, an Oncolytic Therapy, Reduces Adenomas and Modifies Colon Microenvironment in Mouse Model of CRC by Shea F. Grenier, Mohammad W. Khan, Katherine A. Reil, Savannah Sawaged, Shingo Tsuji, Matthew J. Giacalone, Mengxi Tian, Kathleen L. McGuire

Get full text